Latest Updates

Rheumatology: Osteoarthritis 

Christopher Wise, MD, FACP
    • 2016 Update on glucosamine for the management of osteoarthritis
    • 2014 NICE guidelines for osteoarthritis care and management
    • 2014 OARSI guidelines for non-surgical management knee osteoarthritis
    • 2013 AAOS guidelines for knee osteoarthritis
    • 2012 ACR recommendations for therapies in hand/hip/knee osteoarthritis

Nephrology: Metabolic Acidosis 

Shuchi Anand, Lisa Cohen, Dipal Savla
    • Research advances in the field of metabolic acidosis have focused on the pathologic effects of prolonged metabolic acidosis. There is increasing evidence that an acidic milieu is associated with adverse clinical outcomes, including increased risk of renal disease progression, fracture risk, and, in some studies, all-cause mortality. 
    • There has been a shift in conceptualizing acid-base disturbances to incorporate models of strong and weak acids into the traditional, bicarbonate-based equations of Henderson and Hasselbalch. Since its introduction in 1983, the Stewart model of acid-base balance has enhanced understanding of acid-base disorders by including strong ion difference, weak acids and their buffers, dissociation of water, dissolved strong anions, and carbon dioxide as variables that affect serum pH. 
    • Large doses of acetaminophen could cause lactic acidosis via the accumulation of 5-oxoproline (pyroglutamic acid), a result of glutathione depletion.

Nephrology: Acute Kidney Injury in the Cancer Patient

Albert Q. Lam, MD, Shveta Motwani, MD, MMSc, FASN
    • A systematic approach to acute kidney injury in the cancer patient
    • An updated reference table of nephrotoxic chemotherapeutic agents that includes newer drugs, such as tyrosine kinase inhibitors and immune checkpoint inhibitors
    • Discussion of a recently introduced classification system for thrombotic microangiopathy in the cancer patient
    • Discussion of the evolving role of the nephrologist in the care of patients diagnosed with renal cell carcinoma

Rheumatology: Primary Sjögren Syndrome: Etiology and Pathogenesis 

E. William St. Clair, MD, Stephanie L Giattino, MD
    • Genetic studies highlighting several new non–major histocompatibility complex loci associated with primary Sjögren syndrome
    • New insights into lymphoma pathogenesis, with the discovery of genetic variants in some of the tumors that activate the NFkB pathway
    • Further experiments in animal models of Sjögren syndrome–like disease illuminating pathways of immune dysregulation paralleling human disease
    • Translation of new knowledge about disease mechanisms into promising therapies

Squamous Cell Carcinoma: Epidemiology, Risk Factors, and Treatment Options

Jeffrey M Farma, MD, FACS, Elena P Lamb, MD, MS
    • Risk factors for patients at risk for developing multiple squamous cell skin cancers include exposure to UV solar radiation, long-term immunosuppression, exposure to ionizing radiation, and certain genetic disorders
    • Treatment modalities can be divided into surgical and nonsurgical therapies, although surgical therapy is generally the mainstay of treatment
    • Treatment options should be stratified for low- and high-risk SCC. Primary treatment options for low-risk SCC include (1) curettage and electrodesiccation, (2) excision with postoperative margin assessment (POMA) with 4 to 6 mm margins, and (3) radiation therapy (RT) for nonsurgical candidates. Options for high-risk SCC lesions include (1) Mohs surgery or resection with complete circumferential peripheral and deep margin assessment, (2) excision with POMA with wider surgical margins and primary or delayed repair, and (3) RT for nonsurgical candidates

Gastrointestinal Tract and Abdomen: Malignant Diseases of the Peritoneum and Retroperitoneum

Amanda K. Arrington, MD
    • Hyperthermic intra-abdominal chemotherapy treatment in the setting of colorectal carcinomatosis, gastric carcinomatosis, pseudomyxoma peritonei
    • Enhanced understanding of the pathophysiology of pseudomyxoma peritonei

Sarcomas of the Breast

Sanjay P Bagaria, MD, Corbin A Rayfield, MD, Nabil Wasif, MD, MPH
    • Breast sarcomas are typically larger than adenocarcinomas and grow rapidly
    • Skin changes suggest angiosarcoma, and punch biopsy is diagnostic
    • Mastectomy is recommended in most cases
    • Routine nodal sampling is not recommended
    • Five-year survival for breast sarcoma is 60%

Sarcomas of the Breast

Sanjay P Bagaria, MD, Corbin A Rayfield, MD, Nabil Wasif, MD, MPH
    • Breast sarcomas are typically larger than adenocarcinomas and grow rapidly
    • Skin changes suggest angiosarcoma, and punch biopsy is diagnostic
    • Mastectomy is recommended in most cases
    • Routine nodal sampling is not recommended
    • Five-year survival for breast sarcoma is 60%
« Previous | Next »
Updates per yearSpecialty updatesNumber of sections